Covestor’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Buy
19
+2
+12% +$84 ﹤0.01% 2278
2026
Q1
$1K Sell
17
-15
-47% -$714 ﹤0.01% 2111
2025
Q4
$1K Buy
32
+7
+28% +$284 ﹤0.01% 2134
2025
Q3
$1K Buy
25
+9
+56% +$297 ﹤0.01% 2146
2025
Q2
$0 Sell
16
-3
-16% -$65 ﹤0.01% 2607
2025
Q1
$0 Buy
19
+10
+111% +$223 ﹤0.01% 2591
2024
Q4
$0 Sell
9
-46
-84% -$1.06K ﹤0.01% 2598
2024
Q3
$1K Sell
55
-26
-32% -$502 ﹤0.01% 2062
2024
Q2
$1K Buy
81
+1
+1% +$16 ﹤0.01% 2081
2024
Q1
$1K Sell
80
-61
-43% -$731 ﹤0.01% 2059
2023
Q4
$2K Sell
141
-5
-3% -$56 ﹤0.01% 1873
2023
Q3
$2K Buy
146
+17
+13% +$241 ﹤0.01% 1841
2023
Q2
$2K Sell
129
-257
-67% -$3.68K ﹤0.01% 1854
2023
Q1
$6K Buy
386
+35
+10% +$535 0.01% 1529
2022
Q4
$5K Buy
351
+121
+53% +$1.62K ﹤0.01% 1584
2022
Q3
$3K Buy
230
+220
+2,200% +$3.8K ﹤0.01% 1634
2022
Q2
$0 Sell
10
-8
-44% -$152 ﹤0.01% 2230
2022
Q1
$0 Sell
18
-3
-14% -$61 ﹤0.01% 2342
2021
Q4
$0 Buy
+21
New +$448 ﹤0.01% 2244

Other funds holding PAHC

Covestor's PAHC Position: Q2 2026 in Review

Covestor increased its Phibro Animal Health (PAHC) stake by 12% in Q2 2026, buying an estimated $84 and bringing the position to 19 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Covestor first reported a position in PAHC in Q4 2021 and has held it in 19 quarters since. The position peaked at $6K in Q1 2023. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Covestor held 19 shares of Phibro Animal Health worth $1K as of Q2 2026.
  • Covestor bought 2 Phibro Animal Health shares in Q2 2026, an estimated $84.
  • Phibro Animal Health made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2278 holding.
  • Covestor first reported a position in Phibro Animal Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Phibro Animal Health position peaked at $6K in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.